REVB FY 2023 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$25,049

Operating Income

-$9M

Net Income

-$120,254

EPS (Diluted)

$-8.41

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$155,721

Balance Sheet

Total Assets

$12M

Total Liabilities

$6M

Stockholders' Equity

$7M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$25,049	-$40,008	+37.4%
Operating Income	-$9M	-$11M	+20.3%
Net Income	-$120,254	-$11M	+98.9%